Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: A meta-analysis

Shi Yi Wang, Tatyana Shamliyan, Beth A. Virnig, Robert Kane

Research output: Contribution to journalReview articlepeer-review

123 Scopus citations


While ductal carcinoma in situ (DCIS) is seldom life threatening, the management of DCIS remains a dilemma for patients and their physicians. Aggressive treatment reduces the risk of ipsilateral breast tumor recurrence (IBTR), but has never been proven to improve survival. There is interest in identifying the prognostic factors for determining low-risk DCIS patients, but a comprehensive review of high-quality evidence on tumor characteristics in predicting local recurrence has never been carried out. We examined the following tumor characteristics: biomarkers, comedonecrosis, focality, surgical margin, method of detection, tumor grade, and tumor size. For this systematic review we restricted the analyses to the results of subgroup analyses from randomized controlled trials (RCTs) and multivariate analyses from RCTs and observational studies. We identified 44 eligible articles. The pooled random-effects risk estimates for IBTR are comedonecrosis 1.71(95% CI, 1.36-2.16), focality 1.95(95% CI, 1.59-2.40), margin 2.25(95% CI, 1.77-2.86), method of detection 1.35(95% CI, 1.12-1.62), tumor grade 1.81(95% CI, 1.53-2.13), and tumor size 1.63(95% CI, 1.30-2.06). Limited evidence indicated that women whose DCIS is ER-negative, PR-negative, or HER2/neu receptor positive have an IBTR higher than those whose DCIS is ER-positive, PR-positive, and HER2/neu receptor negative. A variety of tumor characteristics are significant predictors for IBTR. These results are important for both clinicians and patients to interpret the risk of local recurrence and to decide on a course of treatment.

Original languageEnglish (US)
Pages (from-to)1-14
Number of pages14
JournalBreast Cancer Research and Treatment
Issue number1
StatePublished - May 2011

Bibliographical note

Funding Information:
Acknowledgments This study was supported by the grant of the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, under Contract No. 290-02-10064-I. The authors of this report are responsible for its content. Statements in this article should not be construed as an endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.


  • Ductal carcinoma in situ
  • Meta-analysis
  • Outcome research
  • Predictors
  • Tumor characteristics


Dive into the research topics of 'Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: A meta-analysis'. Together they form a unique fingerprint.

Cite this